Skip to main navigation Skip to search Skip to main content

Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation

  • Kevin Baßler
  • , Wataru Fujii
  • , Theodore S. Kapellos
  • , Erika Dudkin
  • , Nico Reusch
  • , Ari Horne
  • , Benedikt Reiz
  • , Malte D. Luecken
  • , Collins Osei-Sarpong
  • , Stefanie Warnat-Herresthal
  • , Lorenzo Bonaguro
  • , Jonas Schulte-Schrepping
  • , Allon Wagner
  • , Patrick Günther
  • , Carmen Pizarro
  • , Tina Schreiber
  • , Rainer Knoll
  • , Lisa Holsten
  • , Charlotte Kröger
  • , Elena De Domenico
  • Matthias Becker, Kristian Händler, Christian T. Wohnhaas, Florian Baumgartner, Meike Köhler, Heidi Theis, Michael Kraut, Marc H. Wadsworth, Travis K. Hughes, Humberto J. Ferreira, Emily Hinkley, Ines H. Kaltheuner, Matthias Geyer, Christoph Thiele, Alex K. Shalek, Andreas Feißt, Daniel Thomas, Henning Dickten, Marc Beyer, Patrick Baum, Nir Yosef, Anna C. Aschenbrenner, Thomas Ulas, Jan Hasenauer, Fabian J. Theis, Dirk Skowasch, Joachim L. Schultze
  • University of Bonn
  • aimed analytics
  • Kyoto Prefectural University of Medicine Graduate School of Medical Science
  • Comma Soft AG
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • German Center for Neurodegenerative Diseases (DZNE)
  • Department of Electrical Engineering and Computer Sciences
  • Center for Computational Biology
  • University of Bonn and University Hospital Bonn
  • Boehringer-Ingelheim Pharma GmbH
  • Massachusetts Institute of Technology
  • Massachusetts Institute of Technology
  • Chan Zuckerberg Biohub
  • Amalia Children's Hospital

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Despite its high prevalence, the cellular and molecular mechanisms of chronic obstructive pulmonary disease (COPD) are far from being understood. Here, we determine disease-related changes in cellular and molecular compositions within the alveolar space and peripheral blood of a cohort of COPD patients and controls. Myeloid cells were the largest cellular compartment in the alveolar space with invading monocytes and proliferating macrophages elevated in COPD. Modeling cell-to-cell communication, signaling pathway usage, and transcription factor binding predicts TGF-β1 to be a major upstream regulator of transcriptional changes in alveolar macrophages of COPD patients. Functionally, macrophages in COPD showed reduced antigen presentation capacity, accumulation of cholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction, reminiscent of impaired immune activation.

Original languageEnglish
Article number917232
JournalFrontiers in Immunology
Volume13
DOIs
StatePublished - 28 Jul 2022

Keywords

  • TGF-β1
  • blood
  • bronchoalveolar lavage
  • chronic obstructive pulmonary disease
  • impaired immune activation
  • macrophage
  • monocyte

Fingerprint

Dive into the research topics of 'Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation'. Together they form a unique fingerprint.

Cite this